Pharmacodynamic synthesis method, including 0.01-1.5 mg/ml GLP-1 poison, which does not contain 36 kinds of termination of pregnancy-4(1-39) -lys6-NH2 or at least one salt, thyroxine, or optionally at least one precursor, without hysteria； preparation method； used in the treatment of diabetes mellitus.
Liquid Pharmaceutical composition comprising a glp-1 agonist and methionine； production method； and use for treating diabetes mellitus.<；p>；Composició；n farmacé；utica lí；quida que comprende un agonista de GLP-1 y metionina； mé；todo de fabricació；n； y uso para tratar diabetes mellitus.<；/p>；
